- CardiMED Medical Technology Co., Ltd., Shanghai, 201100, P. R. China;
ZHOU Yaxiong,
Email: zhouyx@cardimed.com.cn
Along with the coming of aged society, the prevalence of heart valvular disease is significantly increasing, and the use of bioprosthetic valves for treating patients with severe valve disease has increased over the last two decades. As a consequence, a growing number of patients with surgical bioprosthesis degeneration is predicted in the near future. In this setting, valve-in-valve (ViV) transcatheter aortic/mitral valve replacement (TAVR/TMVR) has emerged as an alternative to redo surgery. A deep knowledge of the mechanism and features of the failed bioprosthetic heart valve is pivotal to plan an adequate procedure. Multimodal imaging is fundamental in the diagnostic and pre-procedural phases. The immediate and mid-term clinical and hemodynamic results have demonstrated the safety and feasibility of ViV techniques, but the development of these techniques faces several specific challenges, such as coronary obstruction, potential post-procedural mismatch and leaflet thrombosis. This article reviews the current status and prospects of ViV-TAVR technology in the treatment for biological valve degeneration, and suggests that ViV-TAVR should be promoted and implemented in existing medical centers with good surgical aortic valve replacement experience, so as to provide better treatment for patients.
Citation： ZHOU Yaxiong. Status and prospect of transcatheter valve-in-valve implantation for biological valve degeneration. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(5): 800-806. doi: 10.7507/1007-4848.202209047 Copy
| 1. | Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study. J Am Coll Cardiol, 2020, 76(25): 2982-3021. |
| 2. | Yang Y, Wang Z, Chen Z, et al. Current status and etiology of valvular heart disease in China: A population-based survey. BMC Cardiovasc Disord, 2021, 21(1): 339. |
| 3. | Nitsche C, Kammerlander AA, Knechtelsdorfer K, et al. Determinants of bioprosthetic aortic valve degeneration. JACC Cardiovasc Imaging, 2020, 13(2 Pt 1): 345-353. |
| 4. | Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med, 2005, 2(2): 60-61. |
| 5. | Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol, 2004, 43(4): 698-703. |
| 6. | Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med, 2019, 380(18): 1695-1705. |
| 7. | Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715. |
| 8. | Salaun E, Clavel MA, Rodés-Cabau J, et al. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation. Heart, 2018, 104(16): 1323-1332. |
| 9. | Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: A consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg, 2017, 52(3): 408-417. |
| 10. | Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA, 2014, 312(2): 162-170. |
| 11. | Dvir D, Barbanti M, Tan J, et al. Transcatheter aortic valve-in-valve implantation for patients with degenerative surgical bioprosthetic valves. Curr Probl Cardiol, 2014, 39(1): 7-27. |
| 12. | Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of transcatheter aortic valve replacement. J Am Coll Cardiol, 2020, 76(21): 2492-2516. |
| 13. | Taramasso M, Candreva A, Pozzoli A, et al. Current challenges in interventional mitral valve treatment. J Thorac Dis, 2015, 7(9): 1536-1542. |
| 14. | Bapat VN, Attia RQ, Condemi F, et al. Fluoroscopic guide to an ideal implant position for Sapien XT and CoreValve during a valve-in-valve procedure. JACC Cardiovasc Interv, 2013, 6(11): 1186-1194. |
| 15. | Dunning J, Graham RJ, Thambyrajah J, et al. Stentless vs. stented aortic valve bioprostheses: A prospective randomized controlled trial. Eur Heart J, 2007, 28(19): 2369-2374. |
| 16. | Phan K, Tsai YC, Niranjan N, et al. Sutureless aortic valve replacement: A systematic review and meta-analysis. Ann Cardiothorac Surg, 2015, 4(2): 100-111. |
| 17. | Chhatriwalla AK, Sorajja P. Expanding indications for bioprosthetic valve fracture and bioprosthetic valve remodeling. Circ Cardiovasc Interv, 2018, 11(8): e007017. |
| 18. | Allen KB, Chhatriwalla AK, Cohen DJ, et al. Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation. Ann Thorac Surg, 2017, 104(5): 1501-1508. |
| 19. | Nielsen-Kudsk JE, Christiansen EH, Terkelsen CJ, et al. Fracturing the ring of small mitroflow bioprostheses by high-pressure balloon predilatation in transcatheter aortic valve-in-valve implantation. Circ Cardiovasc Interv, 2015, 8(8): e002667. |
| 20. | Saxon JT, Allen KB, Cohen DJ, et al. Complications of bioprosthetic valve fracture as an adjunct to valve-in-valve TAVR. Struct Heart, 2019, 3: 92-99. |
| 21. | Allen KB, Chhatriwalla AK, Saxon JT, et al. Bioprosthetic valve fracture: Technical insights from a multicenter study. J Thorac Cardiovasc Surg, 2019, 158(5): 1317-1328. |
| 22. | Chhatriwalla A, Allen KB, Saxon JT, et al. 1-year outcomes following bioprosthetic valve fracture to facilitate valve-in-valve transcatheter aortic valve replacement. Struct Heart, 2021, 5: 312-318. |
| 23. | Sathananthan J, Fraser R, Hatoum H, et al. A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention. EuroIntervention, 2020, 15(16): 1409-1416. |
| 24. | Allen KB, Chhatriwalla AK, Yousef A, et al. Bioprosthetic valve fracture performed before versus after VIV TAVR: Impact of high-pressure balloon inflation on leaflet calcification. ISMICS Virtual 2020. Available online: https://meetings.ismics.org/abstracts/2020/C9.cgi. |
| 25. | Saxon JT, Allen KB, Cohen DJ, et al. Bioprosthetic valve fracture during valve-in-valve TAVR: Bench to bedside. Interv Cardiol, 2018, 13(1): 20-26. |
| 26. | Johnston DR, Soltesz EG, Vakil N, et al. Long-term durability of bioprosthetic aortic valves: Implications from 12, 569 implants. Ann Thorac Surg, 2015, 99(4): 1239-1247. |
| 27. | Généreux P, Piazza N, et al. Valve academic research consortium 3: Updated endpoint definitions for aortic valve clinical research. Eur Heart J, 2021, 42(19): 1825-1857. |
| 28. | Rodriguez-Gabella T, Voisine P, Dagenais F, et al. Long-term outcomes following surgical aortic bioprosthesis implantation. J Am Coll Cardiol, 2018, 71(13): 1401-1412. |
| 29. | Testa L, Latib A, Brambilla N, et al. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis. Eur Heart J, 2020, 41(20): 1876-1886. |
| 30. | Pibarot P, Herrmann HC, Wu C, et al. Standardized definitions for bioprosthetic valve dysfunction following aortic or mitral valve replacement: JACC state-of-the-art review. J Am Coll Cardiol, 2022, 80(5): 545-561. |
| 31. | Dvir D, Bourguignon T, Otto CM, et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation, 2018, 137(4): 388-399. |
| 32. | Galderisi M, Cosyns B, Edvardsen T, et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: An expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 2017, 18(12): 1301-1310. |
| 33. | Achenbach S, Delgado V, Hausleiter J, et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr, 2012, 6(6): 366-380. |
| 34. | Blanke P, Weir-McCall JR, Achenbach S, et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR): An expert consensus document of the Society of Cardiovascular Computed Tomography. JACC Cardiovasc Imaging, 2019, 12(1): 1-24. |
| 35. | Leetmaa T, Hansson NC, Leipsic J, et al. Early aortic transcatheter heart valve thrombosis: Diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv, 2015, 8(4): e001596. |
| 36. | Blanke P, Soon J, Dvir D, et al. Computed tomography assessment for transcatheter aortic valve in valve implantation: The vancouver approach to predict anatomical risk for coronary obstruction and other considerations. J Cardiovasc Comput Tomogr, 2016, 10(6): 491-499. |
| 37. | Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry. Eur Heart J, 2018, 39(8): 687-695. |
| 38. | Wong I, Bieliauskas G, Søndergaard L, et al. The antegrade-retrograde technique applied in uncrossable valve-in-valve TAVR: A step-by-step guide. JACC Cardiovasc Interv, 2021, 14(2): 227-229. |
| 39. | Deeb GM, Chetcuti SJ, Reardon MJ, et al. 1-year results in patients undergoing transcatheter aortic valve replacement with failed surgical bioprostheses. JACC Cardiovasc Interv, 2017, 10(10): 1034-1044. |
| 40. | Edelman JJ, Khan JM, Rogers T, et al. Valve-in-valve TAVR: State-of-the-art review. Innovations (Phila), 2019, 14(4): 299-310. |
| 41. | Reul RM, Ramchandani MK, Reardon MJ. Transcatheter aortic valve-in-valve procedure in patients with bioprosthetic structural valve deterioration. Methodist Debakey Cardiovasc J, 2017, 13(3): 132-141. |
| 42. | Piazza N, Bleiziffer S, Brockmann G, et al. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: From concept to clinical application and evaluation (part 1). JACC Cardiovasc Interv, 2011, 4(7): 721-732. |
| 43. | Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Results from the global valve-in-valve registry. Circulation, 2012, 126(19): 2335-2344. |
| 44. | Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: Preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv, 2015, 8(1): e002079. |
| 45. | Buono A, Bettari L, Pero G, et al. Valve-in-valve procedure for failed aortic bioprosthesis with the novel acurate neo2 and mini-chimney stenting due to high coronary risk obstruction. Cardiovasc Revasc Med, 2021, 31: 95-96. |
| 46. | Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: Results from the Multicenter International BASILICA Registry. JACC Cardiovasc Interv, 2021, 14(9): 941-948. |
| 47. | Dayan V, Vignolo G, Soca G, et al. Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging, 2016, 9(8): 924-933. |
| 48. | Pibarot P, Simonato M, Barbanti M, et al. Impact of pre-existing prosthesis-patient mismatch on survival following aortic valve-in-valve procedures. JACC Cardiovasc Interv, 2018, 11(2): 133-141. |
| 49. | Chakravarty T, Søndergaard L, Friedman J, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: An observational study. Lancet, 2017, 389(10087): 2383-2392. |
| 50. | Silaschi M, Conradi L, Treede H, et al. Trends in surgical aortic valve replacement in more than 3, 000 consecutive cases in the era of transcatheter aortic valve implantations. Thorac Cardiovasc Surg, 2016, 64(5): 382-389. |
| 51. | Tam DY, Rocha RV, Wijeysundera HC, et al. Surgical valve selection in the era of transcatheter aortic valve replacement in the Society of Thoracic Surgeons Database. J Thorac Cardiovasc Surg, 2020, 159(2): 416-427. |
| 52. | Simonato M, Dvir D. Transcatheter aortic valve replacement in failed surgical valves. Heart, 2019, 105(Suppl 2): s38-s43. |
| 53. | Landes U, Webb JG, De Backer O, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol, 2020, 75(16): 1882-1893. |
| 54. | Liew A, Eikelboom JW, O'Donnell M, et al. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants. Can J Cardiol, 2013, 29(7 Suppl): S34-S44. |
| 55. | Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med, 2017, 377(19): 1847-1857. |
| 56. | Rodriguez-Gabella T, Voisine P, Puri R, et al. Aortic bioprosthetic valve durability: Incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol, 2017, 70(8): 1013-1028. |
| 57. | Yerasi C, Rogers T, Forrestal BJ, et al. Transcatheter versus surgical aortic valve replacement in young, low-risk patients with severe aortic stenosis. JACC Cardiovasc Interv, 2021, 14(11): 1169-1180. |
| 58. | Sathananthan J, Hensey M, Landes U, et al. Long-term durability of transcatheter heart valves: Insights from bench testing to 25 years. JACC Cardiovasc Interv, 2020, 13(2): 235-249. |
| 59. | Wood DA, Lauck SB, Cairns JA, et al. The vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: The 3M TAVR study. JACC Cardiovasc Interv, 2019, 12(5): 459-469. |
| 60. | Barbanti M, van Mourik MS, Spence MS, et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: The multicentre European FAST-TAVI trial. EuroIntervention, 2019, 15(2): 147-154. |
| 61. | Barker M, Sathananthan J, Perdoncin E, et al. Same-day discharge post-transcatheter aortic valve replacement during the COVID-19 pandemic: The multicenter PROTECT TAVR study. JACC Cardiovasc Interv, 2022, 15(6): 590-598. |
| 62. | 孙立忠. 《心脏瓣膜病外科治疗中国专家共识》序言. 中华胸心血管外科杂志, 2022, 38(3): 129-129. |
| 63. | 中国医师协会心血管内科医师分会结构性心脏病专业委员, 中华医学会心血管病学分会结构性心脏病学组. 经导管主动脉瓣置换术中国专家共识. 中国介入心脏病学杂志, 2015, 23(12): 661-667. |
| 64. | 经导管主动脉瓣置换术流程优化共识专家组. 经导管主动脉瓣置换术(TAVR)流程优化专家共识2022版. 中华急诊医学杂志, 2022, 31(2): 154-160. |
| 65. | 赵振燕, 宋光远, 王墨杨, 等. 主动脉瓣生物瓣毁损后行经导管主动脉瓣置换术的安全性及可行性初步研究. 中国分子心脏病学杂志, 2020, 20(3): 3382-3386. |
| 66. | 尚艳文, 关欣, 付博, 等. 超声心动图在经导管主动脉瓣置换-瓣中瓣手术治疗外科生物瓣衰败中的应用研究. 中国循环杂志, 2022, 37(4): 368-373. |
| 67. | Attia RQ, Raja SG. Surgical pericardial heart valves: 50 years of evolution. Int J Surg, 2021, 94: 106121. |
| 68. | Eggebrecht H, Vaquerizo B, Moris C, et al. Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): Insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). Eur Heart J, 2018, 39(8): 676-684. |
| 69. | Stassano P, Di Tommaso L, Monaco M, et al. Aortic valve replacement: A prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol, 2009, 54(20): 1862-1868. |
| 70. | Leviner DB, Witberg G, Levi A, et al. Mechanical vs. bioprosthetic aortic valve replacement in patients younger than 70 years of age: A hazard ratio meta-analysis. Can J Cardiol, 2022, 38(3): 355-364. |
- 1. Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study. J Am Coll Cardiol, 2020, 76(25): 2982-3021.
- 2. Yang Y, Wang Z, Chen Z, et al. Current status and etiology of valvular heart disease in China: A population-based survey. BMC Cardiovasc Disord, 2021, 21(1): 339.
- 3. Nitsche C, Kammerlander AA, Knechtelsdorfer K, et al. Determinants of bioprosthetic aortic valve degeneration. JACC Cardiovasc Imaging, 2020, 13(2 Pt 1): 345-353.
- 4. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med, 2005, 2(2): 60-61.
- 5. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol, 2004, 43(4): 698-703.
- 6. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med, 2019, 380(18): 1695-1705.
- 7. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
- 8. Salaun E, Clavel MA, Rodés-Cabau J, et al. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation. Heart, 2018, 104(16): 1323-1332.
- 9. Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: A consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg, 2017, 52(3): 408-417.
- 10. Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA, 2014, 312(2): 162-170.
- 11. Dvir D, Barbanti M, Tan J, et al. Transcatheter aortic valve-in-valve implantation for patients with degenerative surgical bioprosthetic valves. Curr Probl Cardiol, 2014, 39(1): 7-27.
- 12. Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of transcatheter aortic valve replacement. J Am Coll Cardiol, 2020, 76(21): 2492-2516.
- 13. Taramasso M, Candreva A, Pozzoli A, et al. Current challenges in interventional mitral valve treatment. J Thorac Dis, 2015, 7(9): 1536-1542.
- 14. Bapat VN, Attia RQ, Condemi F, et al. Fluoroscopic guide to an ideal implant position for Sapien XT and CoreValve during a valve-in-valve procedure. JACC Cardiovasc Interv, 2013, 6(11): 1186-1194.
- 15. Dunning J, Graham RJ, Thambyrajah J, et al. Stentless vs. stented aortic valve bioprostheses: A prospective randomized controlled trial. Eur Heart J, 2007, 28(19): 2369-2374.
- 16. Phan K, Tsai YC, Niranjan N, et al. Sutureless aortic valve replacement: A systematic review and meta-analysis. Ann Cardiothorac Surg, 2015, 4(2): 100-111.
- 17. Chhatriwalla AK, Sorajja P. Expanding indications for bioprosthetic valve fracture and bioprosthetic valve remodeling. Circ Cardiovasc Interv, 2018, 11(8): e007017.
- 18. Allen KB, Chhatriwalla AK, Cohen DJ, et al. Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation. Ann Thorac Surg, 2017, 104(5): 1501-1508.
- 19. Nielsen-Kudsk JE, Christiansen EH, Terkelsen CJ, et al. Fracturing the ring of small mitroflow bioprostheses by high-pressure balloon predilatation in transcatheter aortic valve-in-valve implantation. Circ Cardiovasc Interv, 2015, 8(8): e002667.
- 20. Saxon JT, Allen KB, Cohen DJ, et al. Complications of bioprosthetic valve fracture as an adjunct to valve-in-valve TAVR. Struct Heart, 2019, 3: 92-99.
- 21. Allen KB, Chhatriwalla AK, Saxon JT, et al. Bioprosthetic valve fracture: Technical insights from a multicenter study. J Thorac Cardiovasc Surg, 2019, 158(5): 1317-1328.
- 22. Chhatriwalla A, Allen KB, Saxon JT, et al. 1-year outcomes following bioprosthetic valve fracture to facilitate valve-in-valve transcatheter aortic valve replacement. Struct Heart, 2021, 5: 312-318.
- 23. Sathananthan J, Fraser R, Hatoum H, et al. A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention. EuroIntervention, 2020, 15(16): 1409-1416.
- 24. Allen KB, Chhatriwalla AK, Yousef A, et al. Bioprosthetic valve fracture performed before versus after VIV TAVR: Impact of high-pressure balloon inflation on leaflet calcification. ISMICS Virtual 2020. Available online: https://meetings.ismics.org/abstracts/2020/C9.cgi.
- 25. Saxon JT, Allen KB, Cohen DJ, et al. Bioprosthetic valve fracture during valve-in-valve TAVR: Bench to bedside. Interv Cardiol, 2018, 13(1): 20-26.
- 26. Johnston DR, Soltesz EG, Vakil N, et al. Long-term durability of bioprosthetic aortic valves: Implications from 12, 569 implants. Ann Thorac Surg, 2015, 99(4): 1239-1247.
- 27. Généreux P, Piazza N, et al. Valve academic research consortium 3: Updated endpoint definitions for aortic valve clinical research. Eur Heart J, 2021, 42(19): 1825-1857.
- 28. Rodriguez-Gabella T, Voisine P, Dagenais F, et al. Long-term outcomes following surgical aortic bioprosthesis implantation. J Am Coll Cardiol, 2018, 71(13): 1401-1412.
- 29. Testa L, Latib A, Brambilla N, et al. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis. Eur Heart J, 2020, 41(20): 1876-1886.
- 30. Pibarot P, Herrmann HC, Wu C, et al. Standardized definitions for bioprosthetic valve dysfunction following aortic or mitral valve replacement: JACC state-of-the-art review. J Am Coll Cardiol, 2022, 80(5): 545-561.
- 31. Dvir D, Bourguignon T, Otto CM, et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation, 2018, 137(4): 388-399.
- 32. Galderisi M, Cosyns B, Edvardsen T, et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: An expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 2017, 18(12): 1301-1310.
- 33. Achenbach S, Delgado V, Hausleiter J, et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr, 2012, 6(6): 366-380.
- 34. Blanke P, Weir-McCall JR, Achenbach S, et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR): An expert consensus document of the Society of Cardiovascular Computed Tomography. JACC Cardiovasc Imaging, 2019, 12(1): 1-24.
- 35. Leetmaa T, Hansson NC, Leipsic J, et al. Early aortic transcatheter heart valve thrombosis: Diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv, 2015, 8(4): e001596.
- 36. Blanke P, Soon J, Dvir D, et al. Computed tomography assessment for transcatheter aortic valve in valve implantation: The vancouver approach to predict anatomical risk for coronary obstruction and other considerations. J Cardiovasc Comput Tomogr, 2016, 10(6): 491-499.
- 37. Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry. Eur Heart J, 2018, 39(8): 687-695.
- 38. Wong I, Bieliauskas G, Søndergaard L, et al. The antegrade-retrograde technique applied in uncrossable valve-in-valve TAVR: A step-by-step guide. JACC Cardiovasc Interv, 2021, 14(2): 227-229.
- 39. Deeb GM, Chetcuti SJ, Reardon MJ, et al. 1-year results in patients undergoing transcatheter aortic valve replacement with failed surgical bioprostheses. JACC Cardiovasc Interv, 2017, 10(10): 1034-1044.
- 40. Edelman JJ, Khan JM, Rogers T, et al. Valve-in-valve TAVR: State-of-the-art review. Innovations (Phila), 2019, 14(4): 299-310.
- 41. Reul RM, Ramchandani MK, Reardon MJ. Transcatheter aortic valve-in-valve procedure in patients with bioprosthetic structural valve deterioration. Methodist Debakey Cardiovasc J, 2017, 13(3): 132-141.
- 42. Piazza N, Bleiziffer S, Brockmann G, et al. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: From concept to clinical application and evaluation (part 1). JACC Cardiovasc Interv, 2011, 4(7): 721-732.
- 43. Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Results from the global valve-in-valve registry. Circulation, 2012, 126(19): 2335-2344.
- 44. Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: Preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv, 2015, 8(1): e002079.
- 45. Buono A, Bettari L, Pero G, et al. Valve-in-valve procedure for failed aortic bioprosthesis with the novel acurate neo2 and mini-chimney stenting due to high coronary risk obstruction. Cardiovasc Revasc Med, 2021, 31: 95-96.
- 46. Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: Results from the Multicenter International BASILICA Registry. JACC Cardiovasc Interv, 2021, 14(9): 941-948.
- 47. Dayan V, Vignolo G, Soca G, et al. Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging, 2016, 9(8): 924-933.
- 48. Pibarot P, Simonato M, Barbanti M, et al. Impact of pre-existing prosthesis-patient mismatch on survival following aortic valve-in-valve procedures. JACC Cardiovasc Interv, 2018, 11(2): 133-141.
- 49. Chakravarty T, Søndergaard L, Friedman J, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: An observational study. Lancet, 2017, 389(10087): 2383-2392.
- 50. Silaschi M, Conradi L, Treede H, et al. Trends in surgical aortic valve replacement in more than 3, 000 consecutive cases in the era of transcatheter aortic valve implantations. Thorac Cardiovasc Surg, 2016, 64(5): 382-389.
- 51. Tam DY, Rocha RV, Wijeysundera HC, et al. Surgical valve selection in the era of transcatheter aortic valve replacement in the Society of Thoracic Surgeons Database. J Thorac Cardiovasc Surg, 2020, 159(2): 416-427.
- 52. Simonato M, Dvir D. Transcatheter aortic valve replacement in failed surgical valves. Heart, 2019, 105(Suppl 2): s38-s43.
- 53. Landes U, Webb JG, De Backer O, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol, 2020, 75(16): 1882-1893.
- 54. Liew A, Eikelboom JW, O'Donnell M, et al. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants. Can J Cardiol, 2013, 29(7 Suppl): S34-S44.
- 55. Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med, 2017, 377(19): 1847-1857.
- 56. Rodriguez-Gabella T, Voisine P, Puri R, et al. Aortic bioprosthetic valve durability: Incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol, 2017, 70(8): 1013-1028.
- 57. Yerasi C, Rogers T, Forrestal BJ, et al. Transcatheter versus surgical aortic valve replacement in young, low-risk patients with severe aortic stenosis. JACC Cardiovasc Interv, 2021, 14(11): 1169-1180.
- 58. Sathananthan J, Hensey M, Landes U, et al. Long-term durability of transcatheter heart valves: Insights from bench testing to 25 years. JACC Cardiovasc Interv, 2020, 13(2): 235-249.
- 59. Wood DA, Lauck SB, Cairns JA, et al. The vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: The 3M TAVR study. JACC Cardiovasc Interv, 2019, 12(5): 459-469.
- 60. Barbanti M, van Mourik MS, Spence MS, et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: The multicentre European FAST-TAVI trial. EuroIntervention, 2019, 15(2): 147-154.
- 61. Barker M, Sathananthan J, Perdoncin E, et al. Same-day discharge post-transcatheter aortic valve replacement during the COVID-19 pandemic: The multicenter PROTECT TAVR study. JACC Cardiovasc Interv, 2022, 15(6): 590-598.
- 62. 孙立忠. 《心脏瓣膜病外科治疗中国专家共识》序言. 中华胸心血管外科杂志, 2022, 38(3): 129-129.
- 63. 中国医师协会心血管内科医师分会结构性心脏病专业委员, 中华医学会心血管病学分会结构性心脏病学组. 经导管主动脉瓣置换术中国专家共识. 中国介入心脏病学杂志, 2015, 23(12): 661-667.
- 64. 经导管主动脉瓣置换术流程优化共识专家组. 经导管主动脉瓣置换术(TAVR)流程优化专家共识2022版. 中华急诊医学杂志, 2022, 31(2): 154-160.
- 65. 赵振燕, 宋光远, 王墨杨, 等. 主动脉瓣生物瓣毁损后行经导管主动脉瓣置换术的安全性及可行性初步研究. 中国分子心脏病学杂志, 2020, 20(3): 3382-3386.
- 66. 尚艳文, 关欣, 付博, 等. 超声心动图在经导管主动脉瓣置换-瓣中瓣手术治疗外科生物瓣衰败中的应用研究. 中国循环杂志, 2022, 37(4): 368-373.
- 67. Attia RQ, Raja SG. Surgical pericardial heart valves: 50 years of evolution. Int J Surg, 2021, 94: 106121.
- 68. Eggebrecht H, Vaquerizo B, Moris C, et al. Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): Insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). Eur Heart J, 2018, 39(8): 676-684.
- 69. Stassano P, Di Tommaso L, Monaco M, et al. Aortic valve replacement: A prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol, 2009, 54(20): 1862-1868.
- 70. Leviner DB, Witberg G, Levi A, et al. Mechanical vs. bioprosthetic aortic valve replacement in patients younger than 70 years of age: A hazard ratio meta-analysis. Can J Cardiol, 2022, 38(3): 355-364.